Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved

Nature Genetics

Volumn 42, Issue 6, 2010, Pages 498-503

  Comas, Ĩaki ^a   Chakravartti, Jaidip ^b   Small, Peter M ^c   Galagan, James ^d   Niemann, Stefan ^e   Kremer, Kristin ^f   Ernst, Joel D ^b   Gagneux, Sebastien ^a,g,h  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BILL AND MELINDA GATES FOUNDATION   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e RESEARCH CENTER BORSTEL   (Germany)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^h UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DNA SEQUENCE; GENETIC CONSERVATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE;

ANTIGENS, BACTERIAL; CONSERVED SEQUENCE; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77952841173     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.590     Document Type: Article

References (53)

1. Global tuberculosis control-surveillance, planning, fnancing (Report no. WHO/HTM/TB/2008.393). (World Health Organization, Geneva, 2009).
2. Shenoi, S. & Friedland, G. Extensively drug-resistant tuberculosis: a new face to an old pathogen. Annu. Rev. Med. 60, 307-320 (2009).
3. Hershberg, R. et al. High functional diversity in Mycobacterium tuberculosis driven by genetic drift and human demography. PLoS Biol. 6, e311 (2008).
4. Baker, L., Brown, T., Maiden, M.C. & Drobniewski, F. Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg. Infect. Dis. 10, 1568-1577 (2004).
5. Filliol, I. et al. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fngerprinting systems, and recommendations for a minimal standard SNP set. J. Bacteriol. 188, 759-772 (2006).
6. Gutacker, M.M. et al. Single-nucleotide polymorphism-based population genetic analysis of Mycobacterium tuberculosis strains from 4 geographic sites. J. Infect. Dis. 193, 121-128 (2006).
7. Gagneux, S. et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 2869-2873 (2006).
8. Gagneux, S. & Small, P.M. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect. Dis. 7, 328-337 (2007).
9. Reed, M.B. et al. Major Mycobacterium tuberculosis lineages associate with patient country of origin. J. Clin. Microbiol. 47, 1119-1128 (2009).
10. Comas, I. & Gagneux, S. The past and future of tuberculosis research. PLoS Pathog. 5, e1000600 (2009).
11. Woolhouse, M.E., Webster, J.P., Domingo, E., Charlesworth, B. & Levin, B.R. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet. 32, 569-577 (2002).
12. Brunham, R.C., Plummer, F.A. & Stephens, R.S. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect. Immun. 61, 2273-2276 (1993).
13. Dawkins, R. & Krebs, J.R. Arms races between and within species. Proc. R. Soc. Lond. B 205, 489-511 (1979).
14. Kawashima, Y. et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 458, 641-645 (2009).
15. Farci, P. et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344 (2000).
16. Jeffares, D.C. et al. Genome variation and evolution of the malaria parasite Plasmodium falciparum. Nat. Genet. 39, 120-125 (2007).
17. Urwin, R. et al. Distribution of surface protein variants among hyperinvasive meningococci: implications for vaccine design. Infect. Immun. 72, 5955-5962 (2004).
18. North, R.J. & Jung, Y.J. Immunity to tuberculosis. Annu. Rev. Immunol. 22, 599-623 (2004).
19. Shafer, R.W. & Edlin, B.R. Tuberculosis in patients infected with human immunodefciency virus: perspective on the past decade. Clin. Infect. Dis. 22, 683-704 (1996).
20. Lewinsohn, D.A. et al. Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B. PLoS Pathog. 3, 1240-1249 (2007).
21. Bruns, H. et al. Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J. Clin. Invest. 119, 1167-1177 (2009).
22. Gutierrez, C. et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog. 1, e5 (2005).
23. Cole, S.T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544 (1998).
24. Brennan, M.J. & Delogu, G. The PE multigene family: a 'molecular mantra' for mycobacteria. Trends Microbiol. 10, 246-249 (2002).
25. Supply, P. et al. Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area. Mol. Microbiol. 47, 529-538 (2003).
26. Ernst, J.D. et al. Meeting report: NIH workshop on the tuberculosis immune epitope database. Tuberculosis (Edinb) 88, 366-370 (2008).
27. Sassetti, C.M., Boyd, D.H. & Rubin, E.J. Genes required for mycobacterial growth defned by high density mutagenesis. Mol. Microbiol. 48, 77-84 (2003).
28. Sassetti, C.M. & Rubin, E.J. Genetic requirements for mycobacterial survival during infection. Proc. Natl. Acad. Sci. USA 100, 12989-12994 (2003).
29. Jordan, I.K., Rogozin, I.B., Wolf, Y.I. & Koonin, E.V. Essential genes are more evolutionarily conserved than are nonessential genes in bacteria. Genome Res. 12, 962-968 (2002).
30. Plotkin, J.B., Dushoff, J. & Fraser, H.B. Detecting selection using a single genome sequence of M. tuberculosis and P. falciparum. Nature 428, 942-945 (2004).
31. Frank, S.A. & Bush, R.M. Barriers to antigenic escape by pathogens: trade-off between reproductive rate and antigenic mutability. BMC Evol. Biol. 7, 229 (2007).
32. Small, P.M. et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N. Engl. J. Med. 328, 1137-1144 (1993).
33. Warren, R.M. et al. Patients with active tuberculosis often have different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med. 169, 610-614 (2004).
34. Daley, C.L. et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodefciency virus. An analysis using restriction-fragment-length polymorphisms. N. Engl. J. Med. 326, 231-235 (1992).
35. Blaser, M.J. & Kirschner, D. The equilibria that allow bacterial persistence in human hosts. Nature 449, 843-849 (2007).
36. Rodrigo, T. et al. Characteristics of tuberculosis patients who generate secondary cases. Int. J. Tuberc. Lung Dis. 1, 352-357 (1997).
37. Mukadi, Y. et al. Spectrum of immunodefciency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 342, 143-146 (1993).
38. Fraser, C., Hollingsworth, T.D., Chapman, R., de Wolf, F. & Hanage, W.P. Variation in HIV-1 set-point viral load: epidemiological analysis and an evolutionary hypothesis. Proc. Natl. Acad. Sci. USA 104, 17441-17446 (2007).
39. Young, D.B., Perkins, M.D., Duncan, K. & Barry, C.E. Confronting the scientifc obstacles to global control of tuberculosis. J. Clin. Invest. 118, 1255-1265 (2008).
40. Andersen, P. & Doherty, T.M. Opinion: the success and failure of BCG\implications for a novel tuberculosis vaccine. Nat. Rev. Microbiol. 3, 656-662 (2005).
41. Colditz, G.A. et al. Effcacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J. Am. Med. Assoc. 271, 698-702 (1994).
42. Pizza, M. et al. Identifcation of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816-1820 (2000).
43. Abdallah, A.M. et al. Type VII secretion-mycobacteria show the way. Nat. Rev. Microbiol. 5, 883-891 (2007).
44. Rocha, E.P. et al. Comparisons of dN/dS are time dependent for closely related bacterial genomes. J. Theor. Biol. 239, 226-235 (2006).
45. Holt, K.E. et al. High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat. Genet. 40, 987-993 (2008).
46. Li, H., Ruan, J. & Durbin, R. Mapping short DNA sequencing reads and callin variants using mapping quality scores. Genome Res. 18, 1851-1858 (2008).
47. Tamura, K., Dudley, J., Nei, M. & Kumar, S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24, 1596-1599 (2007).
48. Guindon, S. & Gascuel, O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52, 696-704 (2003).
49. Posada, D. & Crandall, K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 14, 817-818 (1998).
50. Ronquist, F. & Huelsenbeck, J.P. MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, 1572-1574 (2003).
51. Yang, Z. PAML 4: phylogenetic analysis by maximum likelihood. Mol. Biol. Evol. 24, 1586-1591 (2007).
52. Vilella, A.J., Blanco-Garcia, A., Hutter, S. & Rozas, J. VariScan: Analysis of evolutionary patterns from large-scale DNA sequence polymorphism data. Bioinformatics 21, 2791-2793 (2005).
53. Korber, B. Computational Analysis of HIV Molecular Sequences (Kluwer Academic Publishers, Dordrecht, The Netherlands, 2000).